Case Challenges: Strategies for Selection and Sequencing of Advanced Treatment Options in MS - National Multiple Sclerosis Society

Skip to navigation Skip to content

Case Challenges: Strategies for Selection and Sequencing of Advanced Treatment Options in MS


September 1, 2014 - September 1, 2015

Recurring Event
An Interactive CME program with patient case videos.

Target Audience:  Physicians, nurses, nurse practitioners and other interested clinicians involved in the care and management of patients with MS.

Learning Objectives:
Upon completion of this CE activity, participants should be better able to:

  1. Explain the mechanisms of inflammation and neurodegeneration and their role in the progression of MS
  2. Evaluate clinical trial data on current and emerging agents and their impact on mechanisms of immunomodulation and/or neuroprotection/CNS repair
  3. Recognize factors that will influence the staging and sequencing of current and emerging therapies for the management of MS
  4. Develop individualized management plans for MS patients using appropriate risk-benefit ratio analysis and therapeutic strategy


Research Update:
Advances in Multiple Sclerosis Disease Management—Research Update   Clyde E. Markowitz, MD

Case Challenge 1:
Current and Emerging Treatment Choices: Can Novel Mechanisms of Action Confer Neuroprotection and Immunomodulation?  Anthony T. Reder, MD

Case Challenge 2:
Optimizing Outcomes: Risk-Benefit Analysis, Selection, and Sequencing of Multiple Sclerosis Treatment Options  Patricia K. Coyle, MD

Accreditation and Credit Designation

For Physicians Accreditation:  This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of Mount Sinai Beth Israel and Health Education Alliance. Mount Sinai Health System Hospitals: Mount Sinai Beth Israel, Mount Sinai St. Luke’s and Mount Sinai Roosevelt, are accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:  Beth Israel Medical Center designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credits Available
Physicians - maximum of 1.5 AMA PRA Category 1 Credit(s)TM
Nurses - 1.5 contact hours
All other healthcare professionals completing this activity will be issued a certificate of participation.

For Nurses Accreditation:  Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation:  This activity is awarded 1.5 contact hours of continuing education credit with 0.5 credit in the area of pharmacology

Instructions for Receiving Credits: There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

To successfully earn credit, participants must complete the activity online during the valid credit period that is noted for this activity.

Follow these steps to earn CME/CE credit:

1.  Read the target audience, learning objectives, and faculty disclosures.

2.  Study the educational content.

3.  Complete the program evaluation and posttest.

To receive a certificate, you must receive a passing score of 70% or higher.
Providing you have a passing score, a certificate will be available online (to print) and will be emailed to you.

For questions about this activity please contact Health Education Alliance, Inc. at

Click here to begin CME Activity